Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here is one profitable company that generates reliable profits without sacrificing growth and two that may face some trouble.
Two Stocks to Sell:
Terex (TEX)
Trailing 12-Month GAAP Operating Margin: 5.5%
With humble beginnings as a dump truck company, Terex (NYSE: TEX) today manufactures lifting and material handling equipment designed to move and hoist heavy goods and materials.
Why Does TEX Worry Us?
- Sales trends were unexciting over the last two years as its 6.7% annual growth was below the typical industrials company
- Revenue growth over the past two years was nullified by the company’s new share issuances as its earnings per share fell by 47.3% annually
- Diminishing returns on capital suggest its earlier profit pools are drying up
At $64.24 per share, Terex trades at 12.4x forward P/E. If you’re considering TEX for your portfolio, see our FREE research report to learn more.
Merit Medical Systems (MMSI)
Trailing 12-Month GAAP Operating Margin: 12.2%
Founded in 1987 and now offering over 1,700 patented products across global markets, Merit Medical Systems (NASDAQ: MMSI) manufactures and markets specialized medical devices used in minimally invasive procedures for cardiology, radiology, oncology, critical care, and endoscopy.
Why Are We Wary of MMSI?
- Modest revenue base of $1.54 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Underwhelming 5.2% return on capital reflects management’s difficulties in finding profitable growth opportunities
Merit Medical Systems is trading at $60.31 per share, or 14.9x forward P/E. Read our free research report to see why you should think twice about including MMSI in your portfolio.
One Stock to Buy:
LPL Financial (LPLA)
Trailing 12-Month GAAP Operating Margin: 9%
As the nation's largest independent broker-dealer with no proprietary products of its own, LPL Financial (NASDAQ: LPLA) provides technology, compliance, and business support services to independent financial advisors and institutions who manage investments for retail clients.
Why Will LPLA Outperform?
- Annual revenue growth of 32.1% over the last two years was superb and indicates its market share increased during this cycle
- Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Industry-leading 37.3% return on equity demonstrates management’s skill in finding high-return investments
LPL Financial’s stock price of $289.02 implies a valuation ratio of 12.4x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
